Ocean Biomedical shareholders approve reverse split; CEO Michelle Berrey and multiple directors resign

Ocean Biomedical, Inc.

CEO Michelle Berrey resigned; also resigned as director along with Jack Elias, Bill Owens, Suren Ajjarapu, Amy Griffith.
Stockholders approved reverse stock split in range of 1:2 to 1:250 (43.7M for, 15.8M against).
Elected directors: Chirinjeev Kathuria (28.5M for), Elizabeth Ng (30.3M), Jonathan Kurtis (30.6M), Michael Peterson (30.5M).
2025 Equity Compensation Plan approved (28.8M for, 4.1M against).
Non-binding say-on-pay frequency set to three years (27.2M for three years, 3.2M for two, 1.8M for one).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.